Timely Scans Crucial for Emergency Patients with Blood in Urine
New research reveals that one in ten emergency patients presenting with visible blood in their urine dies within three months of their initial hospital visit. The WASHOUT study, presented at the European Association of Urology Congress (EAU26) in London, highlights the critical necessitate for rapid diagnostic measures, specifically a scan within 48 hours, to improve patient outcomes and reduce preventable deaths.
The WASHOUT Study: A Global Perspective
The WASHOUT study, a landmark investigation, analyzed data from over 8,500 individuals across 380 hospitals worldwide, tracking their medical journeys for 90 days following admission for visible hematuria (blood in the urine). This comprehensive observational study represents the most extensive real-world dataset to date addressing this often-overlooked symptom, which can indicate life-threatening conditions.
The Importance of Early Diagnostic Imaging
Researchers found that prompt diagnostic imaging – either a computed tomography (CT) scan or cystoscopy – performed within 48 hours of emergency admission significantly improved patient prognoses. Patients receiving these investigative procedures experienced reduced mortality risks and shorter hospital stays. Conversely, those discharged without timely examinations faced a 2.5% increased likelihood of death within three months and higher rates of readmission due to unresolved or worsening underlying conditions.
Cancer Detection and Timely Diagnosis
The study likewise revealed that approximately one in four patients presenting with visible blood in their urine had an underlying cancer, most commonly bladder cancer. Early investigative tests within the first 48 hours of admission led to cancer diagnoses within one day on average. Patients discharged without investigation experienced significantly longer diagnostic delays, averaging three weeks.
Current Care Disparities
Currently, patient care varies significantly depending on the hospital and even the physician they see, as there are no globally recognized, evidence-based guidelines for managing hematuria. The WASHOUT study indicates that only about half (53%) of patients receive a scan, and just over a third (35%) undergo surgery. Others are discharged home or admitted for observation.
Patient Advocacy and Real-World Impact
Jacqueline Emeks, a patient advocate involved in the WASHOUT study, shared her personal experience of being diagnosed with a kidney infection and sepsis after presenting with visible blood in her urine. She emphasizes that “blood in the urine should trigger immediate action. It’s not something to watch and wait.” Emeks advocates for quicker triage, earlier investigations, and faster treatment for patients, believing it translates to safer care and a better chance of avoiding severe illness.
Expert Perspectives
Nikita Bhatt, consultant urologist at St Vincent’s University Hospital, Dublin, and lead researcher of the WASHOUT study, stated, “This is the largest study exploring how we should treat people who present at hospital emergency departments with blood in their urine. Our findings show how important it is that doctors take the necessary steps to identify the cause of the problem.”
Prof. Dr. Joost Boormans, a member of the EAU Scientific Congress Office, noted the study’s importance in highlighting the scale of the problem for both patients and healthcare systems. He emphasized the need for immediate diagnosis to reduce the burden on healthcare resources and improve patient outcomes.
Looking Ahead
The research team is working to incorporate the WASHOUT study’s findings into clinical guidelines to standardize and improve care for patients presenting with hematuria. If you experience visible blood in your urine, seeking prompt medical attention is crucial.
Source: https://medicalxpress.com/news/2026-03-scan-emergency-department-patients-blood.html